Evidence map›Paper›PMID 38307026›Full record

ArticleAmerican journal of human genetics2024

Using implementation science to evaluate a population-wide genomic screening program: Findings from the first 20,000 In Our DNA SC participants.

Caitlin G Allen, Kelly J Hunt, Lori L McMahon, Clay Thornhill, Amy Jackson, John T Clark, Katie Kirchoff, Kelli L Garrison, Kimberly Foil, Libby Malphrus and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 1 institution in 1 country.

Caitlin G AllenMedical University of South Carolina, Charleston, SC, USA. Electronic address: allencat@musc.edu.
Kelly J HuntMedical University of South Carolina, Charleston, SC, USA.
Lori L McMahonMedical University of South Carolina, Charleston, SC, USA.
Clay ThornhillMedical University of South Carolina, Charleston, SC, USA.
Amy JacksonMedical University of South Carolina, Charleston, SC, USA.
John T ClarkMedical University of South Carolina, Charleston, SC, USA.
Katie KirchoffMedical University of South Carolina, Charleston, SC, USA.
Kelli L GarrisonMedical University of South Carolina, Charleston, SC, USA.
Kimberly FoilMedical University of South Carolina, Charleston, SC, USA.
Libby MalphrusMedical University of South Carolina, Charleston, SC, USA.
Samantha NormanMedical University of South Carolina, Charleston, SC, USA.
Paula S RamosMedical University of South Carolina, Charleston, SC, USA.
Kelly PerrittMedical University of South Carolina, Charleston, SC, USA.
Caroline BrownMedical University of South Carolina, Charleston, SC, USA.
Leslie LenertMedical University of South Carolina, Charleston, SC, USA.
Daniel P JudgeMedical University of South Carolina, Charleston, SC, USA.
Medical University of South Carolina · US

Funding

Improving Family Cancer History Collection using Social Network, Human Centered Design, and Implementation Science ApproachesK00CA253576 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI ALLEN, CAITLIN GLOECKNER · 2020 to 2024
$443k
NCI NIH HHS K00 CA253576
6 · The paper itself

Abstract

We use the implementation science framework RE-AIM (reach, effectiveness, adoption, implementation, and maintenance) to describe outcomes of In Our DNA SC, a population-wide genomic screening (PWGS) program. In Our DNA SC involves participation through clinical appointments, community events, or at home collection. Participants provide a saliva sample that is sequenced by Helix, and those with a pathogenic variant or likely pathogenic variant for CDC Tier 1 conditions are offered free genetic counseling. We assessed key outcomes among the first cohort of individuals recruited. Over 14 months, 20,478 participants enrolled, and 14,053 samples were collected. The majority selected at-home sample collection followed by clinical sample collection and collection at community events. Participants were predominately female, White (self-identified), non-Hispanic, and between the ages of 40-49. Participants enrolled through community events were the most racially diverse and the youngest. Half of those enrolled completed the program. We identified 137 individuals with pathogenic or likely pathogenic variants for CDC Tier 1 conditions. The majority (77.4%) agreed to genetic counseling, and of those that agreed, 80.2% completed counseling. Twelve clinics participated, and we conducted 108 collection events. Participants enrolled at home were most likely to return their sample for sequencing. Through this evaluation, we identified facilitators and barriers to implementation of our state-wide PWGS program. Standardized reporting using implementation science frameworks can help generalize strategies and improve the impact of PWGS.

Indexed as

Genetic CounselingImplementation ScienceAdultFemaleGenomicsHumansMiddle AgedCDC Tier 1 conditionsfamilial hypercholesterolemiaimplementation scienceinherited cancerpopulation screening

Identifiers

PMID38307026
PMCPMC10940017
OpenAlexW4391432128

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.